Flexible Administration of Sprinkles® in Infants and Young Children in Rural Bangladesh.

The Effectiveness of Flexible Administration of Sprinkles® in a Mixed Population of Anemic and Non-anemic Infants and Young Children in Rural Bangladesh.

Sponsors

Lead Sponsor: The Hospital for Sick Children

Collaborator: Heinz Endowments

Source The Hospital for Sick Children
Brief Summary

Millions of people worldwide are affected by iron deficiency anemia (IDA). IDA is a widespread serious public health problem, especially for infants in developing countries mainly because of inadequate intake of iron due to the poor bioavailability of dietary iron in predominately cereal based diets. One of the ways to combat iron deficiency anemia is by supplementation to targeted populations. Although iron drops have been used, they have been largely unsuccessful in reducing the prevalence of anemia because of compliance, distribution and supply issues. Sprinkles® are a new approach to iron delivery that is as efficacious as iron drops and more acceptable. For Sprinkles® to be implemented into nation-wide programs as a sustainable alternative to current iron supplementation approaches, an optimal model of use and distribution for Sprinkles® needs to be established. By comparing daily versus flexible use of Sprinkles® (60 sachets over 60, 90 and 120 days) among infants and young children aged 6-24 months, the primary objectives are to study the effect of the three administration models of Sprinkles® on changes in: 1. hemoglobin concentration; and 2. compliance or adherence to the intervention. ii. The secondary objective of this study is to determine the acceptability of each of the three intervention models. We hypothesize that adherence will be greater and hemoglobin concentration response will be higher in those given 'flexible' instructions to use all of the Sprinkles® supplied over a specific period of time compared to those given strict instructions for daily use.

Detailed Description

Study Design This study will follow a community-based cluster randomized clinical trial design involving three intervention groups. Total number of villages included in the study will be determined by the availability of the eligible children. In each village, all eligible children will be screened through house-to-house visits. After the screening, all the children will be randomized by village using a table with randomly assorted table into one of three groups: - Daily use of 60 Sprinkles® sachets over 60 days. - Flexible use of 60 Sprinkles® sachets over 90 days. - Flexible use of 60 Sprinkles® sachets over 120 days. In all groups, assessments will be done at baseline, at the end of a group's intervention and at 6 months after intervention in each group for follow-up. The study will take place in Kaligong sub-district in Bangladesh. All villages in Kaligonj sub-district consist of plain agricultural land. Subsistence farming is the major source of livelihood. Rice is the commonly eaten staple mixed with lentil and vegetable curry and occasionally with pieces of fish and meat. Similar to the rest of the plain areas of the country, malnutrition among women and children is widespread, but malaria is extremely uncommon and the prevalence of hookworm is fairly low (less than 2%%).

Overall Status Completed
Start Date 2004-05-01
Completion Date 2005-03-01
Phase N/A
Study Type Interventional
Primary Outcome
Measure Time Frame
hemoglobin concentration at end of treatment and 6 months post-treatment
adherence measured by the number of sachets used end of treatment
Secondary Outcome
Measure Time Frame
Acceptability measured through interview with mothers
weaning food practice at treatment end and 6 months post-treatment
length and weight at treatment end and 6 months post-treatment
morbidity from diarrhea and acute respiratory infections at treatment end and 6 months post treatment
Enrollment 360
Condition
Intervention

Intervention Type: Drug

Intervention Name: Multiple micronutrient supplement (iron)

Eligibility

Criteria:

Inclusion Criteria: - Age 6-24 months. - Hemoglobin concentration > =70 g/L. - Consuming at least one regular meal of complementary food per day. - Reportedly free from any acute or chronic illness. - Permanent resident of the village. - Not receiving any other form of iron supplementation. - Parental consent obtained. Exclusion Criteria: - Severe anemia (hemoglobin concentration <70 g/L).

Gender:

All

Minimum Age:

6 Months

Maximum Age:

24 Months

Healthy Volunteers:

No

Overall Official
Last Name Role Affiliation
Stanley H Zlotkin, PhD Principal Investigator The Hospital for Sick Children, Toronto, Canada
Location
Facility: Research and Evaluation Division, BRAC
Location Countries

Bangladesh

Verification Date

2021-04-01

Responsible Party

Type: Principal Investigator

Investigator Affiliation: The Hospital for Sick Children

Investigator Full Name: Stanley Zlotkin

Investigator Title: Chief, Global Child Health

Keywords
Has Expanded Access No
Condition Browse
Study Design Info

Allocation: Randomized

Intervention Model: Parallel Assignment

Primary Purpose: Treatment

Masking: Single

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact [email protected]. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Research News